Preliminary report of the phase 1 study of the DOT1L inhibitor, pinometostat, EPZ-5676, in children with relapsed or refractory MLL-r acute leukemia: Safety, exposure and target inhibition Meeting Abstract


Authors: Shukla, N.; O'Brien, M. M.; Silverman, L. B.; Pauly, M.; Wetmore, C.; Loh, M. L.; Whitlock, J. A.; Brown, P.; Thomson, B.; Blakemore, S. J.; Daigle, S.; Pimentel, P.; Waters, N. J.; Krivtsov, A. V.; Koche, R.; Armstrong, S. A.; Ho, P. T.; Gore, L.
Abstract Title: Preliminary report of the phase 1 study of the DOT1L inhibitor, pinometostat, EPZ-5676, in children with relapsed or refractory MLL-r acute leukemia: Safety, exposure and target inhibition
Meeting Title: 57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 126
Issue: 23
Meeting Dates: 2015 Dec 5-8
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-12-03
Language: English
ACCESSION: WOS:000368021800049
PROVIDER: wos
Notes: Meeting Abstract: 3792 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos